A long-latency component of the event-related potential (ERP), especially P300, occurs when a subject attends and discriminates stimulus events which differ from one another along some dimension (for example intensity, duration or modality).' P300 has been reported to be associated with cognitive processing,2 and the temporal lobes including hippocampus and amygdala have been proposed as its possible generator sites.34 Thus, any factor which modifies the timing of neural mechanisms underlying perception and cognition may lead to changes in the morphology or latency of P300. There is a general consensus that P300 latency evoked by an auditory target stimulus increases with age by 1-0 to 1-8 m s per year for ages ranging from 20 to 80 years.
Goodin et al'0 demonstrated that P300 latency in demented patients was significantly prolonged as compared with normal controls regardless of the aetiology of dementia. This finding has been supported by other subsequent studies.7" Furthermore, Goodin and Aminoff'2 distinguished between cortical and subcortical dementia by comparing each component of event-related potentials.
The purpose of this study was to examine the utility of P300 as a diagnostic test of dementia both in Alzheimer's disease (AD) and in multi-infarct *Visiting scientist from Medical Research Council External Scientific dementia (MID); to clarify whether there is a correlation between P300 measures and intelligence quotients (IQ) in demented patients; and to evaluate the effect of physostigmine on IQ as well as P300.
Materials and methods

Subjects
Thirteen patients with clinically definite Alzheimer's disease (AD) (9 females and 4 males, mean age 74 years; range 60 to 82 years, mean Wechsler Adult Intelligence Scale (WAIS) score = 69) were diagnosed on the basis of the criteria proposed by the NINCDS-ADRDA work group.13 All patients showed dementia of insidious onset and slow progression, and had no other systemic or brain diseases that could account for the progressive memory disturbance and other cognitive deficits. Other causes of dementia were eliminated by appropriate laboratory tests. A group of 14 Every patient selected showed only a mild to moderate disability since severely demented patients were not capable of performing the test. As normal controls, data of 27 healthy subjects previously reported by US5 were used to compare the age-related parameters, and data of nine oldest subjects among those 27 were used to compare the non-agerelated parameters (see Statistical analysis).
WAIS was tested, without knowledge of P300 results, on the day of P300 recording or no more than 2 days apart. The battery consisted of Verbal Scale determined by six subtests and Performance Scale determined by five subtests.
Five patients each with AD and with MID were given physostigmine with the initial daily dose of 2 mg by mouth divided into four doses during the daytime. The dose was gradually increased up to 10mg per day and was maintained on that level for a week. Approximately 2 weeks after starting the medication, tests of P300 and WAIS were repeated. Each test was actually initiated 30 minutes after the first or the second dose of the test day.
Task and recording procedures
Each subject participated in an oddball paradigm using audi: tory stimulation. The stimulus was a pure tone delivered binaurally through light headphones at an intensity of 75 dB SPL and with the interstimulus interval of 1-4 s. Tones of two different frequencies, I kHz and 2 kHz, were presented at a rate of 85 and 15%, respectively, in a random order. The subject responded to the target stimulus by pressing a pushbutton with his right index finger. The push-button was connected to a lamp which was observed by the experimenters to assess the response capability and accuracy. When patients were unable to maintain their attention to the tones, frequent reminders to perform the task were given by one of the examiners. Two hundred artifact-free trials were averaged in each of two runs of an experiment. Responses from two runs were combined so that averages were based on approximately 340 sweeps for frequent stimuli and 60 sweeps for targets.
EEG activity was recorded from scalp electrodes at Fz, C3, Cz, C4, P3, Pz and P4 (International 10-20 system) which were referred to linked ear lobe electrodes. An electrooculogram (EOG) was recorded by referring an electrode at the glabella to a lateral suborbital electrode below the right eye. Inter-electrode impedance was reduced to below 3K ohm. Time constant of amplifiers was 3 s and the high frequency cut-off was set to I kHz. Trials including artifact were excluded from the averages. Activity was sampled for a total of 768 ms (including a 75 ms pre-stimulus period) at an ordinate period of 1-5ms. The peak amplitude was measured with respect to the prestimulus baseline.
STATISTICAL ANALYSIS L Criteria for abnormalities 1. Amplitude of all components and latencies of Ni and P2 We have studied P300 in 27 healthy subjects ofvarious ages,5 and found that the above parameters were not related to age. In the present study, therefore, nine oldest subjects among those 27 were used as age-matched normal control for intergroup comparison. Student's t test with a one-way analysis of variance was used for statistical analysis.
2. Latencies of N2 and P300 N2 and P300 latencies in individual patients were defined as abnormal if the values were outside the 95% confidence limits based on the regression equation of latencies on age obtained from our previously studied 27 normal subjects.5 As these parameters were found to be related to age,5 the intergroup differences were tested with an analysis of covariance by using data standardised with respect to age. In other words, the actual latency values for each individual subject were standardised to the values for the age 61 All three groups showed waveforms which were essentially the same in amplitude and morphology (fig 1) . In every group, ERPs to target rare tone stimuli showed a prominent P300 component which was not evident in the ERPs to the frequent tone. P1, NI and P2 appeared to be different in latency among the three groups (fig 1) , but the difference did not reach the statistical significance (table 1) .
N2 and P300 latencies in the two dementia groups were significantly prolonged compared with the normal group (fig 1, table 1 ). N2 latency in all patients but one of each patient group was greater than the predicted mean value for their age. N2 latency was above the 95% confidence limits in 17% of AD patients and in 38% of MID patients. P300 latencies of all demented patients were greater than the predicted mean value for their age (fig 2) . P300 significant negative correlation with WAIS scores, that is, shorter P300 latencies were associated with higher WAIS scores (fig 3, table 2 ). Patients in the AD group tended to have higher correlations between P300 latency and WAIS scores than those in the MID group, but only the Comprehension subtest yielded a correlation which was significantly different between the two groups (p < 0025). P300 amplitude in demented patients did not correlate with WAIS scores.
III. Change after physostigmine treatment In six among 10 patients who were given physostigmine, P300 latency reduced and WAIS scores increased after the medication (fig 4) . In two cases, medication made no difference.to either P300 latency or WAIS scores. In one MID case, the WAIS score decreased and P300 latency became longer. The mean reduction of P300 latency was 18 7ms (paired t = 2-23 NS) and the mean increase in WAIS score was 3 4 points (paired t = 3.8, p < 0.01). Thus, in general, the direction of change in P300 latency and WAIS scores was as expected from the regression line shown in fig 3. In fact, seven of 10 patients showed a change in P300 latency in the direction predicted from the change in WAIS score (p = 0-055, Sign test). With regard to the effect of physostigmine on the WAIS subtests, Picture Arrangement showed the greatest improvement followed by Comprehension. All but two patients were unaware of change in their own performances. Those two cases showed improvement in both P300 latency and WAIS score. Side-effects consisting of nausea and diarrhoea developed in one AD patient at the daily dose of 6 mg. There were no changes in pulse rate, blood pressure, serum electrolytes or liver function tests.
Discussion
The principal findings in this study are (1) a significantly increased latency in approximately 45% of both AD and MID patients for the P300 component of the auditory ERP, (2) a high correlation between P300 latency and WAIS score in demented patients, and (3) a close correspondence between changes in P300 latency and WAIS scores following the administration of physostigmine.
All patients in the present series had P300 latencies greater than the mean values expected from the normal regression equation on age in spite of the fact that all cases had only a mild to moderate disability. This pattern has been found across the previously reported studies7 10 1 and supports the hypothesis that P300 latency is strongly affected by dementing illness. However, the proportion of cases with significantly delayed P300 latency was well below the rate described in those with dementia (80%) (Goodin et all0) and in those with AD (83%) (Syndulko et al7). Brown et all' also reported that P300 latency was significantly prolonged in more than half of 15 demented patients. However, Pfefferbaum et al5 reported that P300 latency was significantly prolonged in fewer than 50% of demented patients. The main difference between those reports seem to lie in the response task required of the subject. Goodin et al,'0 Syndulko et al7 and Brown et al" had their subjects keep mental count, whereas Pfefferbaum et al5 and ourselves used a button-pressing task which might be easier to perform than the count task.
N2 latency in our patient groups was also significantly prolonged compared with the normal control. Ritter et al"6 and Goodin et al '7 reported that N2 and P300 latencies changed almost identically with increasing task difficulty. Since, in the present study. P300 latency was beyond 95% confidence limits in a larger number of demented patients than N2 latency, P300 might be more sensitive to dementing illness than N2.
In the present study, P300 latency was shown to be strongly correlated with WAIS score. The highest negative correlation with P300 latency among the subtests of WAIS was seen for Digit Span, followed by Digit Symbol. The Digit Span subtest involves the oral repeating of two series of numbers one forward and one backward. The observed association between P300 latency and Digit Span, therefore, suggests that these measures may index common dimensions of disrupted cognitive processing. In the clinical interpretation of the WAIS, 8 the Digit Span subtest allows a rapid check on verbal short term memory and attention. According to Hansch et al,"9 a high correlation between Symbol Digit Modality test scores and P300 latency was observed in Parkinson's disease. By testing 20 neurologically normal subjects, Polich et al20 found a negative correlation between P300 latency and Digit Span. Most recently, Homberg et al2" also demonstrated in Huntington's disease that P300 latency was highly correlated with neuropsychologic tests especially requiring concept formation and selective attention.
The P300 component has been associated with a variety of cognitive processes. P300 latency is considered to reflect the speed of neural events underlying perception and discrimination of the target or rare stimulus; matching that particular information against stimulus categories in memory; and making an appropriate decision whether to respond or not.2223 Thus, slowed neural processing involved in stimulus evaluation or decision-making functions is postulated to underlie the associated impairment of P300 latency and Digit Span. In other words, P300 latency appears to be strongly associated with attention and short term memory but not with general intelligence and reasoning.
One of the purposes of this study was to test whether P300 latency might serve as a useful tool to evaluate the effectiveness of specific drugs. Canter et al24 reported that lecithin did not affect EEG spectra or P300 in Alzheimer's disease, which is consistent with reports that lecithin administration alone did not improve memory in patients with Alzheimer's disease. 25 We used physostigmine because its adminNeshige, Barrett, Shibasaki istration has been reported to show memory improvement transiently in demented patients.'8 26 27 In our study, there was a high correlation between the change of P300 latency and that of WAIS score after medication. Furthermore, the WAIS score showed a significant improvement after physostigmine while P300 latency just failed to show a significant reduction (observed t = 2-23, t value for p < 0 05 = 2.25). In fact, had we predicted that P300 latency would decrease after treatment then we could have accepted our P300 result as significant at p < 0 05 on the basis of one-tailed test. It is still difficult to make any conclusion from these findings, however, because the comparison was not performed blind and the effects of practice on both the ERP test and the WAIS need to be taken into consideration although most patients forgot about the ERP or WAIS tested before. Thus, the question as to whether physostigmine improves cognitive function or not awaits further study. However, the results indicate that ERP tests can provide useful objective information in the evaluation of drug effects in demented patients.
